Eurofins Next-Generation Sequencing for Viral Safety

Eurofins’ GMP NGS approach enhances viral safety testing with improved sensitivity and broad detection capability compared to traditional methods. With increasing regulatory acceptance from agencies such as the FDA, ICH, and global authorities, NGS is becoming a modern alternative to legacy HAP, MAP, RAP, and in vivo assays. The method identifies replicating viruses in cell‑based products and leverages a secure bioinformatics pipeline supported by curated databases, ensuring comprehensive detection and strong data integrity.

Get faster testing with GMP NGS. https://www.eurofins.com/biopharma-services/product-testing/services/biopharma-product-testing-services/biosafety-testing/next-generation-sequencing/?utm_source=YouTube&utm_medium=YouTubeOrganic&utm_campaign=NGS&utm_term=NGS

Видео Eurofins Next-Generation Sequencing for Viral Safety канала Eurofins BioPharma Product Testing North America